Metagenomi Inc. Common St...

NASDAQ: MGX · Real-Time Price · USD
1.87
-0.03 (-1.58%)
At close: Aug 15, 2025, 3:59 PM
1.84
-1.60%
After-hours: Aug 15, 2025, 07:49 PM EDT

Metagenomi Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
52.3M 44.76M 17.2M 243K
Cost of Revenue
5.41M 4.21M 1.73M 387K
Gross Profit
52.3M 40.55M 15.47M -144K
Operating Income
-88.9M -78.49M -44.64M -23.95M
Interest Income
14.72M 15.47M 3.42M 43K
Pretax Income
-83.57M -60.23M -41.02M -21.44M
Net Income
-78.06M -68.25M -43.59M -21.44M
Selling & General & Admin
32.02M 28.84M 18.7M 9.71M
Research & Development
109.18M 94.4M 43.14M 14.48M
Other Expenses
n/a -4.21M -1.73M -387K
Operating Expenses
141.2M 119.04M 60.11M 23.8M
Interest Expense
n/a n/a 98K 302K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
141.2M 123.25M 61.84M 24.19M
Income Tax Expense
-5.51M 8.03M 2.57M n/a
Shares Outstanding (Basic)
37.42M 37.47M 37.47M 5.93M
Shares Outstanding (Diluted)
37.42M 37.47M 37.47M 5.93M
EPS (Basic)
-2.09 -1.82 -1.16 -3.62
EPS (Diluted)
-2.09 -1.82 -1.16 -3.62
EBITDA
-83.49M -74.28M -39.19M -20.75M
EBIT
-88.9M -78.49M -40.93M -21.14M
Depreciation & Amortization
5.41M 4.21M 1.73M 387K